Evidence map›Paper›PMID 22938199›Full record

ReviewAntioxidants & redox signaling2013

Reductive stress linked to small HSPs, G6PD, and Nrf2 pathways in heart disease.

Alison C Brewer, Soumyajit Banerjee Mustafi, Thomas V A Murray, Namakkal Soorappan Rajasekaran, Ivor J Benjamin

Abstract readReview
In one paragraph

Review in Antioxidants & redox signaling, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 116 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Observational
  14. Review
  15. Article
  16. ATP-independent molecular chaperone activity generated under reducing conditions.Protein science : a publication of the Protein Society · 2022
    Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Alison C BrewerCardiovascular Division, British Heart Foundation Centre of Research Excellence, King's College, London, UK.
Soumyajit Banerjee Mustafi
Thomas V A Murray
Namakkal Soorappan Rajasekaran
Ivor J Benjamin
University of Utah · USThe King's College · US

Funding

Protein Misfolding Diseases and Oxido-Reductive PathwaysDP1OD006438 · OD · UNIVERSITY OF UTAH · PI BENJAMIN, IVOR JAMES · 2009 to 2011
$2.2M
Reductive Stress in the Pathogenesis of R120GCryAB CardiomyopathyR01HL063834 · NHLBI · UNIVERSITY OF UTAH · PI BENJAMIN, IVOR JAMES · 2000 to 2010
$2.2M
Mechanisms of HSPB2 in Cardiac Metabolism and Ischemic CardioprotectionR01HL074370 · NHLBI · UNIVERSITY OF UTAH · PI BENJAMIN, IVOR JAMES · 2008 to 2011
$1.5M
British Heart Foundation PG/08/110/26228British Heart Foundation PG/11/124/29318British Heart Foundation RE/08/003British Heart Foundation RG/08/011/25922NHLBI NIH HHS 2 R01 HL063834-06NHLBI NIH HHS 5R01HL074370-03NIH HHS 1DP1OD006438-02
6 · The paper itself

Abstract

significanceAerobic organisms must exist between the dueling biological metabolic processes for energy and respiration and the obligatory generation of reactive oxygen species (ROS) whose deleterious consequences can reduce survival. Wide fluctuations in harmful ROS generation are circumvented by endogenous countermeasures (i.e., enzymatic and nonenzymatic antioxidants systems) whose capacity decline with aging and are enhanced by disease states. RECENT ADVANCES: Substantial efforts on the cellular and molecular underpinnings of oxidative stress has been complemented recently by the discovery that reductive stress similarly predisposes to inheritable cardiomyopathy, firmly establishing that the biological extremes of the redox spectrum play essential roles in disease pathogenesis. CRITICAL ISSUES: Because antioxidants by nutritional or pharmacological supplement to prevent or mitigate disease states have been largely disappointing, we hypothesize that lack of efficacy of antioxidants might be related to adverse outcomes in responders at the reductive end of the redox spectrum. As emerging concepts, such as reductive, as opposed, oxidative stress are further explored, there is an urgent and critical gap for biochemical phenotyping to guide the targeted clinical applications of therapeutic interventions. FUTURE DIRECTIONS: New approaches are vitally needed for characterizing redox states with the long-term goal to noninvasively assess distinct clinical states (e.g., presymptomatic, end-stage) with the diagnostic accuracy to guide personalized medicine.

Indexed as

Acetylcysteinealpha-Crystallin B ChainAnimalsAntioxidantsCatalaseDisease Models, AnimalEarly DiagnosisGlucosephosphate DehydrogenaseGlutathioneHeart DiseasesHeat-Shock ProteinsHumansMiceModels, CardiovascularMolecular ChaperonesNeoplasm ProteinsAcetylcysteinealpha-Crystallin B ChainAntioxidantsCatalaseCryab protein, mouseGlucosephosphate DehydrogenaseGlutathioneHeat-Shock ProteinsHsbp1 protein, mouseMolecular ChaperonesNeoplasm ProteinsNFE2L2 protein, humanNF-E2-Related Factor 2PeroxidasesReactive Nitrogen SpeciesReactive Oxygen SpeciesRecombinant Fusion ProteinsSuperoxide DismutaseThioredoxins

Identifiers

PMID22938199
PMCPMC3567781
OpenAlexW2026741807

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.